- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 231.83M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 236.82M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $18.86M |
| Capex | Q1 2026 · Mar 31, 2025 | $29.84M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $75.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $74.22M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $344.51M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $210.58M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.89B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.91B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $194.16M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $177.32M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $934.56M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $879.41M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $673.85M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $577.17M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.83B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.79B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.07 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $102.91M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $100.79M |
| Net Income | Q1 2026 · Mar 31, 2026 | $15.4M |
| Net Income | Q1 2026 · Mar 31, 2025 | $8.31M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $40.73M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $42.48M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $143.65M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $143.28M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $156.55M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $136.27M |